• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An RT-PCR-SSCP screening strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: application to four patients with osteogenesis imperfecta.

作者信息

Mackay K, Byers P H, Dalgleish R

机构信息

Department of Genetics, University of Leicester, UK.

出版信息

Hum Mol Genet. 1993 Aug;2(8):1155-60. doi: 10.1093/hmg/2.8.1155.

DOI:10.1093/hmg/2.8.1155
PMID:7691343
Abstract

A strategy has been developed to allow the screening for mutations in the cDNA of the type I collagen alpha 1 chain. The method involves polymerase chain reaction amplification of four overlapping segments covering the majority of the sequence coding for alpha 1(I) collagen. Four or five restriction endonuclease digestions are performed for each segment and digested samples subjected to single strand conformation polymorphism analysis. Mutations are finally defined by DNA sequence analysis. The application to the detection of mutations in four patients with lethal and non-lethal forms of osteogenesis imperfecta is described. In each of these patients, the heterozygous mutation identified resulted in substitution of different glycine residues with serines. In addition to these deleterious mutations, several novel silent variants were characterised. The strategy provides a rapid approach to screening for mutations and polymorphisms in alpha 1(I) collagen cDNA and is of general interest in scanning large regions of DNA for sequence changes.

摘要

相似文献

1
An RT-PCR-SSCP screening strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: application to four patients with osteogenesis imperfecta.
Hum Mol Genet. 1993 Aug;2(8):1155-60. doi: 10.1093/hmg/2.8.1155.
2
Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybrids.
Nucleic Acids Res. 1990 Jul 25;18(14):4227-36. doi: 10.1093/nar/18.14.4227.
3
Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatch.通过mRNA:cDNA序列错配的化学切割检测到因I型胶原蛋白α2(I)甘氨酸至精氨酸替代导致的致死性围生期成骨不全。
Hum Mutat. 1992;1(1):55-62. doi: 10.1002/humu.1380010109.
4
A novel glycine to glutamic acid substitution at position 343 in the alpha 2 chain of type I collagen in an individual with lethal osteogenesis imperfecta.一名患有致死性成骨不全症的个体中,I型胶原蛋白α2链第343位发生了从甘氨酸到谷氨酸的新型取代。
Hum Mol Genet. 1993 Dec;2(12):2175-7. doi: 10.1093/hmg/2.12.2175.
5
SSCP detection of a Gly565Val substitution in the pro alpha 1(I) collagen chain resulting in osteogenesis imperfecta type II.SSCP检测到原α1(I)胶原链中Gly565Val替代导致II型成骨不全。
Hum Genet. 1993 Jun;91(5):439-44. doi: 10.1007/BF00217768.
6
Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitutions in the alpha 2-chain of type I collagen.三名无亲缘关系的个体患有围生期致死性成骨不全症,该病由I型胶原α2链中相同的甘氨酸502丝氨酸替换所致。
Hum Genet. 1994 Nov;94(5):497-503. doi: 10.1007/BF00211014.
7
Mutation screening by a combination of biotin-SSCP and direct sequencing.通过生物素-单链构象多态性(Biotin-SSCP)与直接测序相结合的方法进行突变筛查。
Hum Genet. 1994 Mar;93(3):287-90. doi: 10.1007/BF00212024.
8
Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta.导致致死性围生期成骨不全的胶原蛋白COL1A1和COL1A2基因点突变的特征分析
J Biol Chem. 1989 Sep 25;264(27):15809-12.
9
Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.由于I型胶原蛋白COL1A2基因突变的亲代嵌合体导致致死性成骨不全复发。嵌合亲代表现出该疾病轻度形式的表型特征。
Hum Mutat. 1992;1(1):47-54. doi: 10.1002/humu.1380010108.
10
Three novel polymorphic sequence variants in the type I collagen gene COL1A1, the main disease locus for Osteogenesis Imperfecta.I型胶原蛋白基因COL1A1中的三个新型多态性序列变体,成骨不全的主要疾病位点。
Mol Cell Probes. 2000 Dec;14(6):329-32. doi: 10.1006/mcpr.2000.0328.

引用本文的文献

1
Targeting defective proteostasis in the collagenopathies.靶向胶原病中的缺陷蛋白稳态。
Curr Opin Chem Biol. 2019 Jun;50:80-88. doi: 10.1016/j.cbpa.2019.02.021. Epub 2019 Apr 24.
2
Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships.II型成骨不全症的突变和多态性谱:对基因型-表型关系的影响。
Hum Mol Genet. 2009 Feb 1;18(3):463-71. doi: 10.1093/hmg/ddn374. Epub 2008 Nov 7.
3
Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.
成骨不全症中I型胶原蛋白的生化筛查:检测α链氨基末端的甘氨酸替代需要通过分子分析进行补充。
J Med Genet. 2006 Aug;43(8):685-90. doi: 10.1136/jmg.2005.040493.
4
Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patient with increased turnover of collagen.III型成骨不全症患者中,COL1A1基因发生甘氨酸511到丝氨酸的替换,伴有胶原蛋白周转率增加。
Mol Cell Biochem. 2003 Jun;248(1-2):49-56. doi: 10.1023/a:1024197213525.
5
Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine.成骨不全症胶原样模型肽的稳定性破坏与取代甘氨酸的残基的特性相关。
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4273-8. doi: 10.1073/pnas.070050097.
6
Substitution of glycine-661 by serine in the alpha1(I) and alpha2(I) chains of type I collagen results in different clinical and biochemical phenotypes.I型胶原α1(I)链和α2(I)链中第661位甘氨酸被丝氨酸取代会导致不同的临床和生化表型。
Hum Genet. 1996 Mar;97(3):324-9. doi: 10.1007/BF02185764.
7
Three unrelated individuals with perinatally lethal osteogenesis imperfecta resulting from identical Gly502Ser substitutions in the alpha 2-chain of type I collagen.三名无亲缘关系的个体患有围生期致死性成骨不全症,该病由I型胶原α2链中相同的甘氨酸502丝氨酸替换所致。
Hum Genet. 1994 Nov;94(5):497-503. doi: 10.1007/BF00211014.
8
A Gly238Ser substitution in the alpha 2 chain of type I collagen results in osteogenesis imperfecta type III.I型胶原蛋白α2链中的Gly238Ser替代导致III型成骨不全症。
Hum Genet. 1995 Feb;95(2):215-8. doi: 10.1007/BF00209405.
9
Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation.
Eur J Pediatr. 1995 Feb;154(2):123-9. doi: 10.1007/BF01991915.
10
Perinatal lethal osteogenesis imperfecta.围产期致死性成骨不全症
J Med Genet. 1995 Apr;32(4):284-9. doi: 10.1136/jmg.32.4.284.